doi:10.16150/j.1671-2870.2019.02.020

Abstract

CLC Number:

R737.9

Figures/Tables 1

References 36

[1]	Hooley RJ, Scoutt LM, Philpotts LE. Breast ultrasonography: state of the art[J]. Radiology, 2013, 268(3):642-659.
[2]	Liu B, Zheng Y, Huang G, et al. Breast Lesions: Quantitative Diagnosis Using Ultrasound Shear Wave Elastography-A Systematic Review and Meta--Analysis[J]. Ultrasound Med Biol, 2016, 42(4):835-847.
[3]	Kwak JY, Kim EK. Ultrasound elastography for thyroid nodules: recent advances[J]. Ultrasonography, 2014, 33(2):75-82.
[4]	Barr RG, Nakashima K, Amy D, et al. WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 2: breast[J]. Ultrasound Med Biol, 2015, 43(5):1148-1160.
[5]	Cosgrove D, Piscaglia F, Bamber J, et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications[J]. Ultraschall Med, 2013, 34(3):238-253.
[6]	Itoh A, Ueno E, Tohno E, et al. Breast disease: clinical application of US elastography for diagnosis[J]. Radiology, 2006, 239(2):341-350.
[7]	Au FW, Ghai S, Moshonov H, et al. Diagnostic performance of quantitative shear wave elastography in the evaluation of solid breast masses: determination of the most discriminatory parameter[J]. Am J Roentgenol, 2014, 203(3):W328-W336.
[8]	Balleyguier C, Ciolovan L, Ammari S, et al. Breast elastography: the technical process and its applications[J]. Diagn Interv Imaging, 2013, 94(5):503-513.
[9]	Youk JH, Son EJ, Park AY, et al. Shear-wave elastography for breast masses: local shear wave speed (m/sec) versus Young modulus(kPa)[J]. Ultrasonography, 2013, 33(1):34-39.
[10]	Lee SH, Cho N, Chang JM, et al. Two-view versus single-view shear-wave elastography: comparison of observer performance in differentiating benign from malignant breast masses[J]. Radiology, 2014, 270(2):344-353.
[11]	Kim S, Choi S, Choi Y, et al. Diagnostic performance of shear wave elastography of the breast according to scanning orientation[J]. J Ultrasound Med, 2014, 33(10):1797-1804.
[12]	Blank MAB, Antaki JF. Breast Lesion Elastography Region of Interest Selection and Quantitative Heterogeneity: A Systematic Review and Meta-Analysis[J]. Ultrasound Med Biol, 2017, 43(2):387-397.
[13]	Youk JH, Son EJ, Han K, et al. Performance of shear-wave elastography for breast masses using different region-of-interest(ROI) settings[J]. Acta Radiol, 2017:284185117735562:1-9.
[14]	Youk JH, Gweon HM, Son EJ. Shear-wave elastography in breast ultrasonography: the state of the art[J]. Ultrasonography. 2017 Oct; 36(4):300-309.
[15]	Park HY, Han KH, Yoon JH, et al. Intra-observer reproducibility and diagnostic performance of breast shear-wave elastography in Asian women[J]. Ultrasound Med Biol, 2014, 40(6):1058-1064.
[16]	Berg WA, Cosgrove DO, Doré CJ, et al. Shear-wave elastography improves the specificity of breast US: the BE1 multinational study of 939 masses[J]. Radiology, 2012, 262(2):435-449.
[17]	Çebi Olgun D, Korkmazer B, Kılıç F, et al. Use of shear wave elastography to differentiate benign and malignant breast lesions[J]. Diagn Interv Radiol, 2014, 20(3):239-244.
[18]	Zhou J, Zhan W, Dong Y, et al. Stiffness of the surroun-ding tissue of breast lesions evaluated by ultrasound elastography[J]. Eur Radiol, 2014, 24(7):1659-1667.
[19]	Tozaki M, Fukuma E. Pattern classification of ShearWave? Elastography images for differential diagnosis between benign and malignant solid breast masses[J]. Acta Radiol, 2011, 52(10):1069-1075.
[20]	Jung CS, Lee SH, Kim HY, et al. Clinical Utility of Shear Wave Elastography Patterns for Differentiating between Benign and Malignant Breast Lesions[J]. J Breast Dis, 2017, 5(2):71-75.
[21]	Hari S, Paul SB, Vidyasagar R, et al. Breast mass chara-cterization using shear wave elastography and ultrasound[J/OL]. Diagn Interv Imaging, 2018-06-10[2018-10-09].https://www.ncbi.nlm.nih.gov/pubmed/30006125.
[22]	Lee SH, Chang JM, Kim WH, et al. Added value of shear-wave elastography for evaluation of breast masses detected with screening US imaging[J]. Radiology, 2014, 273(1):61-69.
[23]	Barr RG, Zhang Z, Cormack JB, et al. Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial[J]. Radiology, 2013, 269(3):701-712.
[24]	Cho N, Lim J, Moon WK. Usefulness of ultrasound elastography in reducing the number of Breast Imaging Reporting and Data System category 3 lesions on ultrasonography[J]. Ultrasonography, 2014, 33(2):98-104.
[25]	Choi WJ, Kim HH, Cha JH, et al. Predicting prognostic factors of breast cancer using shear wave elastography[J]. Ultrasound Med Biol, 2014, 40(2):269-274.
[26]	Chang JM, Park IA, Lee SH, et al. Stiffness of tumours measured by shear-wave elastography correlated with subtypes of breast cancer[J]. Eur Radiol, 2013, 23(9):2450-2458.
[27]	Evans A, Whelehan P, Thompson A, et al. Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy for Primary Breast Cancer Comparing Interim Ultrasound, Shear Wave Elastography and MRI[J]. Ultraschall Med, 2018, 39(4):422-431.
[28]	Jing H, Cheng W, Li ZY, et al. Early Evaluation of Re-lative Changes in Tumor Stiffness by Shear Wave Elastography Predicts the Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer[J]. J Ultrasound Med, 2016, 35(8):1619-1627.
[29]	Tamaki K, Tamaki N, Kamada Y, et al. Non-invasive evaluation of axillary lymph node status in breast cancer patients using shear wave elastography[J]. Tohoku J Exp Med, 2013, 231(3):211-216.
[30]	Youk JH, Son EJ, Kim JA, et al. Pre-Operative Evaluation of Axillary Lymph Node Status in Patients with Suspected Breast Cancer Using Shear Wave Elastography[J]. Ultrasound Med Biol, 2017, 43(8):1581-1586.
[31]	Balleyguier C, Ciolovan L, Ammari S, et al. Breast elastography: the technical process and its applications[J]. Diagn Interv Imaging, 2013, 94(5):503-513.
[32]	Kim MY, Choi N, Yang JH, et al. False positive or negative results of shear-wave elastography in differentiating benign from malignant breast masses: analysis of clinical and ultrasonographic characteristics[J]. Acta Radiol, 2015, 56(10):1155-1162.
[33]	Kılıç F, Kayadibi Y, Kocael P, et al. Changes in the elasticity of fibroadenoma during the menstrual cycle determined by real-time sonoelastography[J]. Eur J Radiol, 2015, 84(6):1044-1048.
[34]	Xue Y, Yao S, Li X, et al. Value of shear wave elastography in discriminating malignant and benign breast lesions: A meta-analysis[J]. Medicine (Baltimore), 2017, 96(42):e7412.
[35]	Lee SH, Chang JM, Kim WH, et al. Differentiation of benign from malignant solid breast masses: comparison of two-dimensional and three-dimensional shear-wave elastography[J]. Eur Radiol, 2013, 23(4):1015-1026.
[36]	Youk JH, Gweon HM, Son EJ, et al. Three-dimensional shear-wave elastography for differentiating benign and malignant breast lesions: comparison with two-dimensio-nal shear-wave elastography[J]. Eur Radiol, 2013, 23(6):1519-1527.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 36

Related Articles 13

Recommended Articles

Metrics

Comments

[1]	HOU Xiaosa, YANG Zhenjiang. Risk factors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(03): 284-289.
[2]	. [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(03): 294-297.
[3]	LI Weiwei, WU Ying, ZHOU Wei, ZHAN Weiwei, ZHOU Qinghua, TAO Lingling, YANG Yanwen. The diagnostic value of smart three-dimensional superb microvascular imaging in differentiating benign and malignant breast lesions of BI-RADS 4 [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(06): 583-587.
[4]	YAN Bing, WANG Haifei, CAO Yunyun, NIU Jianmei. Comparative analysis of ultrasonographic features and clinicopathological types for mucinous breast carcinoma and analysis of the causes for misdiagnosis [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(04): 386-390.
[5]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(03): 325-328.
[6]	LI Weiwei, ZHAN Weiwei, ZHOU Wei, TAO Lingling, WANG Yi, FAN Jinfang, FEI Yuanxin, KUANG Lijun, XU Wenying. The diagnostic value of smart three-dimensional superb microvascular imaging in detecting blood flow distribution pattern of breast lesion [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(2): 139-143.
[7]	WANG Shunli, DENG Shuangshuang, GAO Hui, XIAO Tianyu, GAO Jinli. Analysis of clinicopathological characteristics of breast encapsulated papillarycarcinoma [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 89-92.
[8]	YAO Jiejie, ZHU Ying, ZHAN Weiwei, CHEN Xiaosong, FEI Xiaochun. Correlation of sonographic features of non-mass ductal carcinoma in situ with clinicopathological findings and biomarkers [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(06): 676-681.
[9]	. [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(02): 225-230.
[10]	WU Yan, DING Peifen, GU Yan, GUO Shanyu, DAI Qiancheng, ZHANG Wei. Expression and analysis of HIC-1 and HMMR in breast cancer [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(01): 73-78.
[11]	DA Qian, WU Dongmei, XU Haimin, WANG Chaofu. Clinicopathological characteristics of adenoid cystic carcinoma in breast: report of 10 cases and review of literature [J]. Journal of Diagnostics Concepts & Practice, 2016, 15(06): 608-613.
[12]	. [J]. Journal of Diagnostics Concepts & Practice, 2016, 15(05): 528-531.
[13]	PEI Wenjiang, ZHAO Feng, WU Yan, ZHONG Ming, GAO Hang, LI Yousheng, GU Yan, GUO Shanyu, DAI Qiancheng, ZHANG Wei. Effect of hypermethylated in cancer 1-downstream-regulated gene HMMR on cell migration and invasion in breast cancer: an in vitro study on breast cancer cell line MDA-MB-231 [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(01): 70-75.